News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sassi Nir
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/20/2023 |
4
| Sassi Nir (CFO) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.61, valued at
$64.4k
|
|
| 02/28/2022 |
4
| Sassi Nir (CFO) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $4.18, valued at
$250.8k
|
|
| 08/06/2021 |
4
| Sassi Nir (CFO) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $8.87, valued at
$310.5k
|
|
| 09/18/2020 |
4
| Sassi Nir (CFO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 100,000 options to buy
@ $0.3215, valued at
$32.2k
|
|
| 02/19/2020 |
4
| Sassi Nir (CFO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 90,000 options to buy
@ $0.4287, valued at
$38.6k
|
|
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| Sassi Nir (CFO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 90,000 options to buy
@ $7.628, valued at
$686.5k
|
|
|
|